Confirming a diagnosis of hereditary colorectal cancer: The impact of a familial bowel cancer registry in New Zealand

New Zealand Medical Journal

Volumn 119, Issue 1242, 2006, Pages

  James, Paul A ^a   Parry, Susan ^b   Arnold, Julie ^b   Winship, Ingrid ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2;

ADULT; AGE; CANCER CENTER; CANCER CONTROL; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; COLON POLYPOSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FAMILY STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEREDITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NEW ZEALAND; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT REFERRAL; RELATIVE; REVIEW; SYMPTOM; TUMOR LOCALIZATION; ARTICLE; CLINICAL PROTOCOL; COLORECTAL TUMOR; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MIDDLE AGED; ONSET AGE; REGISTER; STANDARD; STATISTICS;

AGE OF ONSET; CLINICAL PROTOCOLS; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; NEW ZEALAND; REFERRAL AND CONSULTATION; REGISTRIES;

EID: 33749340572     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. New Zealand Health Information Service, New Zealand Ministry of Health. Cancer: New registrations and deaths. Wellington: NZHIS; 2002.
2. Vasen HF, Griffioen G, Offerhaus GJ, et al. The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands. Dis Colon Rectum. 1990;33:227-30.
3. Järvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterology. 2000;118:829-34.
4. Bulow S, Bulow C, Nielsen TF, et al. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish polyposis register. Scand J Gastroenterol. 1995;30:989-93.
5. Heiskanen I, Luostarinen T, Jävinen HJ. Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol. 2000;35:1284-7.
6. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999;116:1453-6.
7. Jass JR. Subsite distribution and incidence of colorectal cancer in New Zealand, 1974-1983. Dis Colon Rectum. 1991;34:56-9.
8. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-8.
9. Glanz K, Grove J, Le Marchand L, Gotay C. Underreporting of family history of colon cancer: correlates and implications. Cancer Epidemiol Biomarkers Prev. 1999;8:635-9.
10. Lynch HT, Smyrk T. Hereditary non-polyposis colorectal cancer (Lynch syndrome). An updated review. Cancer. 1996;78:1149-67.
11. New Zealand Guidelines Group. Surveillance and management of groups at increased risk of colorectal cancer. Wellington: NZGG; 2004.